GBS disability scores increased by one grade or more in 68 % ( 76 of 112 ) of patients in the methylprednisolone group and in 56 % ( 63 of 113 ) of controls ( odds ratio [ OR ] 1.68 , 95 % CI 0.97-2 .88 ; p = 0.06 ) .
